Daily non-political popular news in brief.
Older men treated for early prostate cancer live longer than those who are not
12-12-2006 · EurekAlert!Recent findings of an observational study by researchers at the University of Pennsylvania School of Medicine suggest that men between 65-80 years of age who received treatment for early stage, localized prostate cancer lived significantly longer than men who did not receive treatment. The study will be published in the Dec. 13 issue of JAMA.
Read more »
Keywords: older, men, treated, prostate, cancer, live, longer
« Previous | Next »
Similar news on "Older men treated for early prostate cancer live longer than those who are not":
- Analysis: Older men treated for early prostate cancer live longer than those not treated
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »
- More than 6 months of hormone therapy doesn't help prostate cancer patients live longer
11-05-2006 · EurekAlert!
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- Analysis: Older men treated for early prostate cancer
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »
- Leading researchers to reveal comprehensive dos and don'ts for prostate cancer
10-13-2007 · EurekAlert!
Researchers will share new research on how eating common foods such as tomatoes and fish, maintaining a healthy weight, and avoiding meats cooked at high temperatures may help prevent prostate cancer, and help men live healthier and longer after diagnosis. More widespread studies, in combination with newer technologies in gene research, are substantiating some long-held hypotheses.
Similar news · Read more »
- Combination therapy improves survival for certain prostate cancer patients
01-22-2008 · EurekAlert!
Men with localized prostate cancer who were treated with male hormone suppression therapy and radiation treatment had longer survival, but those with moderate to high levels of other illnesses did not experience this effect, according to a study in the Jan. 23 issue of JAMA.
Similar news · Read more »
- Additional hormone therapy use after radiation for some prostate cancers extends survival
11-06-2006 · EurekAlert!
The largest study examining the benefits of long-term use of hormone therapy after radiation treatment for prostate cancer shows men with aggressive locally advanced disease live longer if hormones are used for an additional 24 months. Research also showed other significant benefits for those with less aggressive cancers who receive hormones.
Similar news · Read more »
- Nonhormonal drug reduces hot flashes in men treated for prostate cancer
06-03-2007 · EurekAlert!
North Central Cancer Treatment Group researchers based at Mayo Clinic in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.
Similar news · Read more »
- Elderly, ill men get unneeded prostate cancer screenings
11-14-2006 · EurekAlert!
A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age.
Similar news · Read more »
- Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
- Radiation therapy combo cures prostate cancer long-term
01-04-2007 · EurekAlert!
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
Similar news · Read more »
